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Transport of dietary cholesterol from endocytic organelles to the endoplasmic reticulum (ER)
is essential for cholesterol homoeostasis, but the mechanism and regulation of this transport
remains poorly defined. Membrane contact sites (MCS), microdomains of close membrane
apposition, are gaining attention as important platforms for non-vesicular, inter-organellar
communication. Here we investigate the impact of ER-endocytic organelle MCS on choles-
terol transport. We report a role for Niemann-Pick type C protein 1 (NPC1) in tethering ER-
endocytic organelle MCS where it interacts with the ER-localised sterol transport protein
Gramd1b to regulate cholesterol egress. We show that artificially tethering MCS rescues the
cholesterol accumulation that characterises NPC1-deficient cells, consistent with direct
lysosome to ER cholesterol transport across MCS. Finally, we identify an expanded population
of lysosome-mitochondria MCS in cells depleted of NPC1 or Gramd1b that is dependent on
the late endosomal sterol-binding protein STARD3, likely underlying the mitochondrial cho-
lesterol accumulation in NPC1-deficient cells.
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Cholesterol is an essential lipid that maintains membraneintegrity and serves as a precursor of several classes ofsignalling molecules. However, cholesterol accumulation
in the endocytic pathway is associated with neurological diseases1,
such as Niemann-Pick type C (NPC), a progressive childhood
neurodegenerative disease characterised on a cellular level by the
accumulation of cholesterol and multiple sphingolipid species in
lysosomes2. Mammalian cells have therefore evolved sophisti-
cated systems to regulate cholesterol homoeostasis. Upon endo-
cytosis, dietary low-density-lipoprotein (LDL)-derived cholesterol
is transported to the ER, where sterol levels are sensed and
endogenous cholesterol biosynthesis is downregulated accord-
ingly3. How cholesterol reaches the ER from endocytic organelles
remains unclear but likely involves several parallel pathways4.
Some LDL-cholesterol is thought to traffic via the plasma mem-
brane, thereby safeguarding plasma membrane cholesterol supply
prior to downregulation of cholesterol production at the ER4.
However, a substantial body of evidence supports direct transport
of approximately 30% of LDL-cholesterol from endosomes to the
ER5,6. The oxysterol-binding protein homologue ORP1L has
recently been implicated in cholesterol transport to the ER7,8.
ORP1L is a late endosomal protein that binds ER-localised vesicle
associated membrane protein (VAMP)-associated proteins
(VAPs) through a conserved FFAT motif9 and this interaction is
important for ORP1L’s role in cholesterol transport10. Studies
using the virally encoded protein RIDα are consistent with a role
for ORP1L in LDL-cholesterol transport to the regulatory pool in
the ER11. Interestingly, under conditions of sterol depletion, the
ORP1L-VAP interaction is implicated in cholesterol transport in
the opposite direction, from ER to endosomes, to support the
formation of intraluminal vesicles (ILV) within the endosome12,
suggesting a role for these membrane contact site (MCS) proteins
in bidirectional cholesterol transport. Another endosomal sterol-
binding protein, STARD3, also interacts with VAPs at the ER to
promote ER to endosome cholesterol transport and ILV
formation13.
NPC disease is caused by mutations in genes encoding lyso-
somal proteins NPC1 (95% of cases) or NPC2 (5% of cases).
NPC1 is a large transmembrane protein, which localises to the
limiting membrane of late endocytic organelles. NPC2 is small
soluble luminal protein that shuttles cholesterol from intra-
lysosomal vesicle membranes to the N-terminal domain of
NPC114. However, the function of NPC1 is less well understood
and it has previously been proposed to be a cholesterol trans-
porter or a cholesterol regulated transporter of multiple sub-
strates. A previous report indicates that NPC1 interacts with the
ER-resident oxysterol-binding protein ORP5 and that both NPC1
and ORP5 are required for LDL-cholesterol egress from endocytic
organelles to the ER15. This finding adds to the body of evidence
suggesting a role for ER-endosome MCS as conduits for direct
LDL-cholesterol transport to the ER16–18.
Here we show that the cholesterol environment of the endo-
cytic pathway influences the interactions made by lysosomal
sterol-binding proteins to define the MCS populations formed
with either ER or mitochondria. We find that NPC1 regulates ER
contact sites with late endocytic organelles where it interacts with
the ER-localised sterol transport protein Gramd1b. Critically,
expansion of the MCS is sufficient to rescue the lysosomal
accumulation of LDL-derived cholesterol in the absence of NPC1
and mediate its transport to the ER.
Results
NPC1 tethers ER contact sites with late endocytic organelles.
Using NPC1-deficient cells as models of defective cholesterol
transport, we investigated the contribution of MCS to the egress
of LDL-cholesterol from endocytic organelles using two com-
plementary techniques: Live-cell fluorescence microscopy,
enabling rapid screening of cellular organelles in their native
environment, and electron microscopy (EM) where the higher
resolution allows the contact itself to be visualised.
We first examined the association between late endosomes/
lysosomes and the ER in control and Npc1−/− Chinese hamster
ovary (CHO) cells by fluorescence microscopy. Using Sec61-GFP
and LysoTracker to visualise ER and lysosomes respectively, we
found significantly reduced association between the two orga-
nelles in Npc1−/− compared to control cells as quantified using
Pearson’s correlation coefficient (Fig. 1a, b). A similar reduction
in co-localization was achieved by acute pharmacological NPC1
inhibition using U18666A, which binds the sterol-sensing domain
of NPC1 and induces cholesterol accumulation19 (Fig. 1a, b).
We previously found that different populations of endocytic
organelles are tethered to the ER by distinct protein complexes.
For example, epidermal growth factor receptor (EGFR)-contain-
ing multi-vesicular endosomes/bodies (MVBs) are tethered by
Annexin-A1 and its calcium-dependent ligand S100A11, while
other non-EGFR populations are tethered by VAPs12. We
therefore examined the relative impact of NPC1 downregulation
(Supplementary Fig. 1a) on different ER-endosome MCS
populations by EM. HeLa cells were stimulated with EGF in the
presence of an antibody to EGFR’s extracellular domain coupled
to gold, to distinguish EGFR-containing endosomes from other
endocytic organelle populations (Fig. 1c). While Annexin-A1-
regulated ER contacts with EGFR-containing MVBs were
unchanged by NPC1 depletion, ER contacts with EGFR-
negative MVBs (nonEGFR-MVBs) and lysosomes were reduced
by approximately 50%, mirroring our previously reported effect
of VAP depletion12 (Fig. 1d). Treatment with U18666A also
specifically reduced ER contacts with nonEGFR-MVBs and
lysosomes (Fig. 1d). Consistent with a role for NPC1 in regulating
MCS, ER-nonEGFR-MVB and ER-lysosome MCS populations
were also significantly reduced in NPC1 patient fibroblasts
compared to controls (Supplementary Fig. 1b). In contrast, these
changes in MCS were not observed in NPC2 patient fibroblasts,
likely because NPC2 is a luminal protein and cannot therefore
function in tethering MCS (Supplementary Fig. 1b).
To further explore the role of NPC1 in stabilising MCS, we
investigated its subcellular localisation by immuno-EM. As
expected, NPC1-GFP (Fig. 1e) or endogenous NPC1 (Fig. 1f
and Supplementary Fig. 1c and d) localised predominantly to the
limiting membrane of late endosomes and lysosomes, including at
ER-endocytic organelle MCS. Furthermore, NPC1 appears
enriched at the MCS, with a six-fold increase in the number of
gold particles per micron of the limiting membrane in contact
with the ER compared to regions not associated with the ER
(Fig. 1g). We next measured the effect of NPC1 overexpression on
the extent of ER-endocytic organelle MCS in NPC-patient
fibroblasts using correlative light and EM to identify NPC1-
GFP-expressing cells (Fig. 1h). ER contacts with endocytic
organelles were significantly extended in cells over-expressing
NPC1-GFP (Fig. 1i, j).
Collectively, the reduction of MCS in the absence of NPC1, the
presence of NPC1 at MCS and the expansion of MCS on NPC1
overexpression, indicate a role for NPC1 in tethering MCS
between late endocytic organelles and the ER.
NPC1 interacts with an ER-localised protein, Gramd1b at
MCS. Having established a role for NPC1 in MCS formation, we
next sought to characterise its interactions at the contact site. A
split reporter reassembly assay20 in yeast, using Ncr1 (yeast
NPC1) as bait, identified Lipid transfer protein Anchored at
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Membrane contact sites-4 (LAM4) as an interacting protein.
LAMs are a family of lipid transporters that contain a GRAM
domain in the pleckstrin homology superfamily and a StART
(Steroidogenic Acute Regulatory protein-related lipid Transfer)-
like domain, both of which are also present in three human
proteins (GramD1a-c)21. Immunoprecipitation (IP) of GFP-
Gramd1a-c proteins revealed a specific interaction between
NPC1 and Gramd1b (Fig. 2a, b) that could also be detected by IP
of endogenous proteins (Fig. 2c). This interaction is influenced by
the sterol environment, as there was a reduction of Gramd1b
coimmunoprecipitated with NPC1 from cells cultured in lipo-
protein deficient serum (LPDS) compared with those cultured in
the presence of full serum (Fig. 2c, d). The expression of both
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(Supplementary Fig. 2a). NPC1 has previously been shown to
interact with ORP5 when both proteins are overexpressed15. We
were unable to detect an interaction between endogenous NPC1
and ORP5 under either sterol condition, but ORP5 expression is
prohibitively low for reliable IPs of endogenous protein.
LAM4 has been shown to localise to the ER in yeast21. Live cell
imaging of Gramd1b-GFP confirmed that Gramd1b is also an
ER-resident protein (Supplementary Fig. 2b). Moreover, we
found that, like NPC1, endogenous Gramd1b localises to
lysosome-ER contact sites (Fig. 2e), including those positive for
NPC1 (Supplementary Fig. 2c), consistent with these two proteins
interacting at MCS. To explore the importance of this interaction
in tethering the contacts, we quantified MCS in cells depleted of
Gramd1b. Gramd1b depletion (Supplementary Fig. 2d) also
reduced ER contacts with nonEGFR-MVBs and lysosomes to a
similar extent as seen in NPC1-deficient cells (Fig. 2f). To further
probe the importance of the Gramd1b interaction in NPC1’s role
at MCS, we examined the effect of Gramd1b depletion on NPC1
localisation at the ER-lysosome interface. The enrichment of
endogenous NPC1 label on late endosomes/lysosomes at sites
of ER contact in control cells (Figs 1g, 2g, i) was lost on depletion
of Gramd1b (Fig. 2h, i, Supplementary fig. 2e and f). This can in
part be explained by the reduction in MCS in Gramd1b-deficient
cells (Fig. 2f), but in late endocytic organelles with an ER
contact, NPC1 label did not decorate the MCS as seen in controls
(Fig. 2h, i). Taken together, these findings demonstrate a sterol-
dependent interaction between sterol-binding proteins Gramd1b
and NPC1 at the ER-lysosome interface to stabilise the
interorganellar association.
NPC1-regulated MCS mediate cholesterol transport to the ER.
In addition to increasing MCS in NPC-patient fibroblasts,
NPC1-GFP expression also rescued the cholesterol accumula-
tion phenotype in the same cells (Supplementary Fig. 3a–d),
suggesting that NPC1-dependent MCS might act as conduits
for the transport of LDL-cholesterol to the ER. Therefore, we
next examined the intracellular localization of an exogenously
added “click”-cholesterol probe (pacChol) that combines a
photoreactive group for UV crosslinking and an alkyne group
for conjugation to an azide22. BSA-complexed pacChol was
taken up by the endolysosomal pathway as indicated by vesi-
cular staining in WT and NPC1−/− cells after a 20 min pulse,
which showed co-localization with the late endosomal marker
LAMP1 (Supplementary Fig. 3e and f) at this early time-point.
Longer chase times of 60 min led to nearly complete clearance
of pacChol from lysosomes in WT cells, now giving rise to a
reticular staining, whereas NPC1−/− cells still retained pacChol
in their lysosomes (Supplementary Fig. 3e and f, quantified in
Supplementary Fig. 3g). These data substantiate a transport
block at late-endosomal / lysosomal stages in NPC1-deficient
cells. Since we have shown that NPC1 is required for MCS
formation (Fig. 1d), this finding suggests that NPC1-regulated
MCS might mediate cholesterol egress from the endocytic
pathway.
We therefore examined the role of the NPC1-Gramd1b
tethering complex in cholesterol egress. Filipin staining revealed
an intracellular accumulation of cholesterol in Gramd1b-depleted
cells, although to a lesser extent than in the absence of NPC1
(Fig. 3a, b). Filipin-stained cholesterol accumulated in a LAMP1-
positive compartment in cells depleted of Gramd1b or NPC1
(Supplementary Fig. 3h), consistent with lysosomal accumulation.
Since Filipin staining only yields qualitative information, we also
sought to quantify intracellular cholesterol biochemically, using
the AmplexRed cholesterol assay. Cells depleted of Gramd1b
show elevated free cholesterol compared to control cells, but
consistent with the Filipin staining, the elevation is weaker than
in cells depleted of NPC1 (Fig. 3c). Gramd1b has recently been
shown to also function in lipid transport at ER-plasma
membrane MCS23. Since disruption of the lipid distribution at
the plasma membrane can affect endocytosis24, we examined LDL
uptake in Gramd1b-depleted cells. However, uptake of
fluorescent-LDL was unchanged in Gramd1b-depleted cells
compared with controls (Supplementary Fig. 3i). We also
measured cholesterol ester levels in these cells as a measure of
transport to the ER since esterification of excess cholesterol is
catalysed by an ER-resident enzyme, Acyl-CoA:cholesterol
acyltransferase (ACAT). Levels of cholesterol esters were
significantly reduced in both NPC1 and Gramd1b-depleted cells
(Fig. 3d), demonstrating impaired cholesterol transport to the ER
when lysosome-ER association is reduced (Fig. 2f).
Fig. 1 NPC1 tethers ER contact sites with late endocytic organelles. a Live-cell confocal microscopy images of ER and late endosomes/lysosomes. WT
Chinese hamster ovary (CHO) cells, NPC1−/− CHO cells and WT CHO cells treated with U18666A (2 µg/ml for 72 h) were transfected with Sec61-GFP for
24 h and incubated with Lysotracker Red (75 nM) for 15 min before imaging. Scale bar, 10 µm. b Quantification of ER and lysosomal co-localization. The
Pearson correlation coefficient between Sec61-GFP and Lysotracker channels was extracted for each cell (WT: n= 24 cells, NPC1−/−: n= 30 cells,
U18666A: n= 27 cells) and presented as boxplots. Centre lines show medians, box limits indicate first (Q1) and third quartiles (Q3), whiskers extend to a
maximum distance of 1.5*IQR (interquartile range) from Q1 and Q3, respectively or to the most extreme datapoint within that range. Welch two sample t-
tests were performed between all conditions (WT-NPC: ***P= 2.8 × 10−15, WT-U18666A: ***P= 8.6 × 10−12, NPC-U18666A: N.S. P= 0.185).
c Representative electron micrographs showing distinct MCS populations. HeLa cells were stimulated with EGF for 25 min in the presence of anti-EGFR
antibody coupled to 10 nm gold prior to preparation for EM. Arrows indicate MCSs between the ER and endocytic organelles. Scale bar, 200 nm.
d Endocytic organelle populations in c were scored according to the presence of MCS with the ER and the percentage of organelles with an ER MCS
quantified. Data shown is the mean of three independent experiments+ SEM. Welch two sample t-tests were performed between siCON and treatment
conditions for each vesicle population (EGFR-MVBs: N.S. P= 0.524, P= 0.470, P= 0.278, nonEGFR-MVBs: ***P= 0.00025, P= 0.00034, P= 0.00071,
Lysosomes: */**P= 0.01859, P= 0.00622, P= 0.00164). e Representative electron micrograph of NPC-patient fibroblasts transfected with NPC1-GFP and
stained for NPC1 using pre-embedding labelling. NPC1-GFP (red arrows) is visible at MCSs (black arrows) between the ER and lysosomes. Scale bar,
200 nm. f Representative electron micrograph showing endogenous NPC1 staining at ER-lysosome MCSs (black arrows) using pre-embedding labelling in
HeLa cells. g Quantification of NPC1 labelling on late endosome/lysosome limiting membrane that is (MCS) or is not (nonMCS) in contact with the ER
(n= 16 late endosomes/lysosomes). h NPC1-GFP was expressed in NPC-patient fibroblasts cultured on gridded dishes and imaged by light microscopy
prior to preparation for EM. EM images of individual cells, identified using grid coordinates, were montaged and the fluorescent image overlaid in order to
distinguish between expressing and non-expressing cells. An expressing cell is shown. Scale bar, 5 μm. i Representative electron micrographs of endocytic
organelles in NPC1gfp-expressing cells showing extended MCSs (arrows). Scale bar, 200 nm. j The length of MCSs was measured in non-transfected
control fibroblasts (Ctrl) and transfected NPC-patient fibroblasts not expressing (NPC) or expressing NPC1-GFP (+NPC1gfp) and expressed as a
percentage of the total endocytic organelle limiting membrane. n= 62 organelles (Ctrl), 60 organelles (NPC) and 84 organelles (+NPC1gfp). Welch two
sample t-tests were performed between all conditions (Ctrl/NPC: ***P= 7.4 × 10−5, Ctrl/NPCgfp: ***P= 1.8 × 10−9, NPC/NPCgfp: ***P < 2.2 × 10−16)
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MCS expansion restores cholesterol egress in NPC1−/− cells.
To further probe the role of MCS in the transfer of LDL-
cholesterol to the ER, we examined the effect of MCS expansion
on cholesterol transport. Overexpression of the MCS protein
ORP1L-GFP dramatically increased ER-lysosome contacts
(Fig. 4a) and also resulted in drastic reduction of accumulated
cholesterol in NPC1-null cells, as shown by Filipin staining
(Fig. 4b, c). However, the oxysterol binding-protein-related
domain (ORD) of ORP1L is known to actively participate in
cholesterol egress7,8. To determine whether ORP1L’s effect is
due to its cholesterol transporting or its tethering properties, we
made use of an ORP1L-delta-ORD mutant (ORP1L-ΔORD)
which is known to act as a constitutively active tether between
late endosomes and the ER without transporting cholesterol
itself10,12,18. Remarkably, NPC1−/− cells expressing ORP1L-
ΔORD-GFP also showed reduced Filipin staining (Fig. 4b, c),
even though LDL uptake was unaffected (Supplementary
Fig. 4a). This reduction in free cholesterol can be attributed to
increased ER-lysosome contacts (Fig. 4a) since in contrast,

























































































































Fig. 2 NPC1 interacts with the ER-localised sterol transport protein Gramd1b at MCSs. a GFP immunoprecipitates from HeLa cells transfected with
Gramd1a-c GFP plasmids were immunoblotted with anti-NPC1 and GFP antibodies. b Quantification of the ratio of NPC to GFP present in a, represented as
a mean of three independent experiments. Welch two sample t-tests were performed between all conditions (Gramd1a/Gramd1b: **P= 0.00275,
Gramd1b/Gramd1c: **P= 0.00836, Gramd1a/Gramd1c: N.S. P= 0.2835). c NPC1 immunoprecipitates from HeLa cells cultured in medium containing 10%
FCS or LPDS for 18 h were immunoblotted with anti-Gramd1b antibody. d Quantification of the amount of Gramd1b as a percentage of NPC1 present in c,
represented as the mean of two experiments. e Representative electron micrograph showing endogenous Gramd1b staining at ER-lysosome MCSs (black
arrows) using pre-embedding labelling in HeLa cells. Scale bar, 100 nm. f Endocytic organelle populations in HeLa cells treated with control, NPC1 or
Gramd1b siRNA were scored according to the presence of MCS with the ER. The percentage of organelles with an ER MCS was quantified and represented
as the mean of three independent experiments+ SEM. Welch two sample t-tests were performed between siCON and treatment conditions for each
vesicle population (EGFR-MVBs: N.S. P= 0.5244, P= 0.197, nonEGFR-MVBs: ***P= 0.00025, **P= 0.00127, Lysosomes: *P= 0.01859, ***P= 0.00038).
g, h Representative electron micrographs showing endogenous NPC1 staining (red arrows) at an ER-lysosome MCS (black arrows) using pre-embedding
labelling in HeLa cells transfected with a non-targeting control siRNA (g) or with siRNA targeting Gramd1b (h). Scale bar, 200 nm. i Quantification of NPC1
labelling on late endosome/lysosome limiting membrane that is (MCS) or is not (nonMCS) in contact with the ER in cells prepared in panels g and h (n=
50 late endosomes/lysosomes per condition)
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motif mutant ORP1L that is unable to tether to the ER10
(Fig. 4b, c).
We also examined the transport of cholesterol to the ER at
these ORP1L-ΔORD-tethered contact sites. To this end, NPC1-
deficient cells expressing ORP1L-ΔORD-GFP were FACS-sorted
for GFP. Overexpression of ORP1L-ΔORD-GFP significantly
decreased the accumulation of free cholesterol and markedly
increased cholesterol esters compared to non-expressing cells
(Fig. 4d, e), indicative of increased transport to the ER. Thus, the
tethering function of ORP1L is critical for cholesterol egress from
late endosomes/lysosomes in NPC1-deficient cells.
To directly correlate the degree of MCS expansion with
cholesterol egress from endocytic organelles, cholesterol staining
in U18666A-treated Hela cells transfected with ORP1L-ΔORD
was examined by immuno-EM. Pre-embedding labelling with the
cholesterol-binding toxin perfringolysin-O (PFO)12,25 was
reduced in endocytic organelles with ORP1L-ΔORD-induced
extended ER MCS (Fig. 4f), revealing an inverse relationship
between the amount of PFO-stained cholesterol in the endocytic
organelle and the proportion of its membrane in contact with the
ER (Fig. 4g). Since pre-embedding labelling requires cell
permeabilisation, and potential loss of membrane cholesterol,
we also used cryo-immunoEM, where ultrathin sections are
labelled without permeabilisation. ORP1L-ΔORD-GFP expres-
sion reduced PFO-labelled cholesterol in endocytic organelles of
U18666A-treated cells by 68% (Supplementary Fig. 4b and c).
Taken together, these data indicate that NPC1-regulated MCS
mediate direct transport of cholesterol from late endocytic
organelles to the ER.
Lysosome-mitochondria MCS are increased in NPC1−/− cells.
EM analysis of cells depleted of NPC1 or Gramd1b (Fig. 5a), or of
NPC1-inhibited cells (Supplementary Fig. 5a), where lysosome-
ER MCS are reduced (Figs. 1d and 2f) uncovered a reciprocal
expansion of a population of MCS between lysosomes and
mitochondria. Closer examination revealed similar contacts with
visible tethers in control cells (Supplementary Fig. 5b) but these
contacts were twice as abundant in cells depleted of NPC1 or
Gramd1b (Fig. 5b) or in U18666A-treated cells (Supplementary
Fig. 5c). Lysosome-like structures occasionally appeared partially
(Supplementary Fig. 5d) or completely (Supplementary Fig. 5e)
engulfed by mitochondria in NPC1-deficient or U18666A-treated
cells. To confirm that these structures are lysosomes, the endo-
cytic pathway was loaded with horseradish peroxidase (HRP)
prior to treatment with U18666A. Electron dense HRP reaction
product was clearly visible in late endocytic organelles, including
those apparently inside mitochondria (Fig. 5c).
This appearance of lysosomes within the mitochondria could
be suggestive of inter-organelle fusion. However, in the example
shown in Fig. 5c, the lysosome is surrounded by a double
membrane, characteristic of the mitochondrial membrane, which
would signify a lack of fusion. ImmunoEM showed that the
membrane around the lysosome was positive for the outer
mitochondria membrane (OMM) protein Tom20 (Fig. 5d).
Moreover, electron tomography showed the lysosome pushing
into, but not through the OMM (Supplementary video). Succes-
sive tomographic slices through the mitochondria show the
mitochondrial membrane surrounding rather than fusing with,


















































































































Fig. 3 NPC1-regulated MCSs mediate cholesterol transport from late endocytic organelles to the ER. a Confocal microscopy images of WT HeLa cells
transfected with control (scrambled) or Gramd1b siRNA as well as NPC1−/− HeLa cells stained with 50 µg/mL Filipin. Scale bars,10 µm. b Quantification of
Filipin intensity in cells treated as described in a. Boxplots show medians as centre lines, box limits indicate first (Q1) and third quartiles (Q3), whiskers are
at a maximum distance of 1.5*IQR (interquartile range) from Q1 and Q3, respectively or to the most extreme datapoint within that range. Outliers are
shown. Welch two sample t-tests were performed between untreated WT condition and treatment conditions: WT-scrambled (n= 95 cells), WT-
siGramd1b (n= 101 cells), NPC1−/− (n= 43 cells). N.S. P= 0.6216, ***P < 2.2 × 10−16, ***P= 4.9 × 10−11. c Quantification of unesterified cholesterol in
HeLa cells treated with non-targeting control (ctrl), NPC1 and Gramd1b siRNAs. Cholesterol was measured using the Amplex Red Cholesterol Assay Kit
and values are presented as mean of five independent experiments+ SD. Welch two sample t-tests were performed between all conditions. ctrl/siNPC1
***P= 0.00063, ctrl/siGramd1b **P= 0.00389, siNPC1/siGramd1b **P= 0.0085. d Quantification of cholesterol esters in HeLa cells treated with control,
NPC1 and Gramd1b siRNAs. Cholesterol esters were measured using the Amplex Red Cholesterol Assay Kit with addition of 0.2 U/mL cholesterol esterase.
Data are represented as mean of five independent experiments+ SD. Welch two sample t-tests were performed between all conditions. ctrl/siNPC1
***P= 0.00012, ctrl/siGramd1b ***P= 0.00033, siNPC1/siGramd1b N.S. P= 0.6758
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absence of NPC1, lysosomes form extensive and stable MCS with
mitochondria, but without membrane fusion between the two
organelles.
Increase in lysosome-mitochondria MCS is STARD3-dependent.
PFO-staining revealed that mitochondria-surrounded lysosomes
are laden with cholesterol (Fig. 6a), suggesting that high lysosome
cholesterol content might promote mitochondrial association.
Elevated mitochondrial cholesterol was previously reported in
NPC cells26, prompting us to speculate that lysosome-
mitochondria MCS could provide an alternative route for cho-
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transfer protein STARD3 has been implicated in LDL-cholesterol
transport to mitochondria26. We found that depletion of
STARD3 (Supplementary Fig. 6a) in NPC-patient fibroblasts
drastically reduced lysosome-mitochondria contacts to a level
well below that in control cells (Fig. 6b, c), indicating an essential
role for STARD3 in the formation of these MCS. STARD3
overexpression is known to promote ER-endocytic organelle
MCS27, but has not previously been implicated in lysosome-
mitochondria contacts. On co-expression of STARD3-GFP with
APEX-GBP (a GFP-binding peptide with a modified soybean
ascorbate peroxidase (APEX) tag28), to allow STARD3 to be
localised by EM, we found ER-endocytic organelle MCS to be
greatly extended in control cells, consistent with previous
reports27, with STARD3-GFP clearly visible as an electron-dense
APEX reaction product at the MCS (Fig. 6d and Supplementary
Fig. 6b). Surprisingly, when cells were treated with the NPC1
inhibitor U18666A, ER contact with late endocytic organelles was
not increased and endosomal STARD3-GFP re-localised to the
expanded lysosome-mitochondria interface (Fig. 6e and Supple-
mentary Fig. 6c).
Thus, we have revealed a dual functionality for STARD3, such
that when ER contact with endocytic organelles is reduced,
resulting in cholesterol accumulation, STARD3 instead promotes
association between the cholesterol-laden lysosomes and
mitochondria.
Taken together, our data demonstrate a role for NPC1 in
tethering ER contact sites with late endocytic organelles that
mediate cholesterol transport to the ER. In NPC1-deficient cells,
where ER contact is reduced, cholesterol accumulates in
lysosomes, which form increased contact with mitochondria,
likely underlying the mitochondrial cholesterol accumulation and
dysfunction in NPC.
Discussion
In this study we have demonstrated an important function for
MCS between the ER and endocytic organelles in transport of
LDL-cholesterol from endocytic organelles to the ER. MCS reg-
ulate multiple mechanisms that could contribute to endocytic
cholesterol export. ER-endosome contacts define sites of endo-
some fission29, possibly of lipid-rich vesicles, for recycling to the
plasma membrane and MCS are also required for retrograde
transport from endosomes to the Golgi30, another proposed route
of cholesterol transport31. The majority of LDL-derived
cholesterol is thought to be trafficked to the ER via the plasma
membrane, to safeguard supply. However, approximately 30% of
total LDL-cholesterol is estimated to undergo direct transport
from the endocytic pathway to the ER for esterification6, by an as
yet unclear mechanism. Here we present several lines of evidence
for direct transport of LDL-cholesterol from endocytic organelles
to the ER across MCS between the two organelles.
Firstly, we uncovered a role for NPC1 as a functional MCS
tethering protein that satisfies all the major criteria of a tether32: it
is enriched at MCS where it interacts with ER-localised Gramd1b
and is functional in mediating MCS formation. Gramd1 proteins
are known to transfer sterols via their StART-like domain and
Gramd1b efficiently transports cholesterol33 and has been
implicated in transport of HDL-derived cholesterol to the ER at
the ER-plasma membrane interface23. Gramd1b recruitment to
ER-plasma MCS was dependent on cholesterol-loading of the
plasma membrane. We found that Gramd1b also interacts with
NPC1 at ER-lysosome contact sites when endosomal cholesterol
is replete, suggesting that this sterol transfer protein is targeted to
contact sites with cholesterol-rich organelles. Our data support a
model of Gramd1b recruitment to lysosomes under conditions of
high LDL-cholesterol in the endocytic pathway, where it interacts
with NPC1 to stabilise the interorganellar association for trans-
port of cholesterol to the ER. However, the accumulation of
unesterified, filipin-stained cholesterol in endocytic organelles
was more pronounced in the absence of NPC1 than Gramd1b,
even though uptake of fluorescent-LDL was unaffected. This
indicates a dual role for NPC1, both in direct transport at
Gramd1b-dependent contact sites and in indirect transport via
the plasma membrane34. Indeed NPC1 was previously shown to
mediate Rab8-dependent recycling of LDL-derived cholesterol to
the plasma membrane34. Given the comparable reduction of
cholesterol esterification in NPC1 or Gramd1b-depleted cells,
Gramd1b is likely to also play a dual role in cholesterol transport
by contributing both to indirect transport via the plasma mem-
brane23 as well as via ER-lysosome contact sites. Interestingly,
Gramd1b has the unique ability to also transfer phosphoinosi-
tides33, suggesting that it may function in a phosphoinositide-
sterol counter exchange mechanism as has been described for
OSBP at the ER-Golgi interface35.
In addition to measuring cholesterol both with filipin staining
and using the Amplex Red assay, we have also demonstrated the
use of a “click”-cholesterol probe to image cholesterol transport.
The probe, complexed with BSA for entry into the endocytic
Fig. 4 Expansion of lysosome-ER contact sites restores cholesterol egress in NPC1-deficient cells. a Electron micrographs showing extended MCSs in HeLa
cells transfected with wtORP1L or ORP1L-ΔORD GFP constructs. Scale bar, 200 nm. b Confocal microscopy images of CHO NPC1−/− cells transfected with
ORP1L-GFP, ORP1L-deltaORD-GFP and ORP1L-FFATmut-GFP for 24 h, fixed and stained with 50 µg/ml Filipin (GFP, yellow; Filipin, cyan). Scale bar, 10 µm.
c Quantification of intracellular Filipin staining in cells treated as described in b. Centre lines show medians, box limits indicate first (Q1) and third quartiles
(Q3), whiskers extend to a maximum distance of 1.5*IQR (interquartile range) from Q1 and Q3, respectively or to the most extreme datapoint within that
range. Welch two sample t-tests were performed between control and expressing cells for each condition (ORP1L: n= 203 cells (Control), n= 39 cells
(Expressing), ***P= 9.1 × 10−10, ORP1L-deltaORD: n= 204 cells (Control), n= 42 cells (Expressing), ***P < 2.2 × 10−16, ORP1L-FFATmut-GFP: n= 202
cells (control), n= 33 cells (Expressing) N.S. P= 0.713,). d Quantification of unesterified cholesterol in WT and NPC1−/− HeLa cells as well as in NPC1−/−
HeLa cells transfected with ORP1L-ΔORD-GFP, with expressing cells sorted by FACS. Cholesterol was measured using the Amplex Red Cholesterol Assay
Kit and values are presented as mean of 5 (WT), 3 (NPC1) or 4 (NPC1+ORP1L) independent experiments+ SD. Welch two sample t-tests were
performed: WT/NPC1−/− **P= 0.00959, NPC1−/−/NPC1−/−+ORP1L-ΔORD *P= 0.04161. e Quantification of cholesterol esters in WT and NPC1−/−
HeLa cells as well as in NPC1−/− HeLa cells transfected with ORP1L-ΔORD-GFP and sorted by FACS. Cholesterol esters were measured using the Amplex
Red Cholesterol Assay Kit with addition of 0.2 U/mL cholesterol esterase. Data are represented as mean of 5 (WT), 3 (NPC1) or 4 (NPC1+ORP1L)
independent experiments+ SD with asterisks indicating statistical significance as determined by Welch two sample t-tests. WT/NPC1−/− *P= 0.01547,
NPC1−/−/NPC1−/−+ORP1L-ΔORD **P= 0.00104. f HeLa cells transfected with ORP1L-deltaORD were treated with U18666A (2 µg/ml for 18 h) and
labelled with PFO prior to preparation for EM. Representative electron micrographs show a lysosome with little/no contact with the ER (likely not
expressing ORP1L-deltaORD) staining strongly for PFO and a lysosome with an extended contact with the ER with greatly reduced PFO labelling. Scale bar,
200 nm. g The percentage of endocytic organelle membrane in contact with the ER in f was measured and plotted against the number of PFO-gold particles
(cholesterol label)/endocytic organelle (n= 30 organelles)
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pathway, was redistributed from the lysosome to the ER after a
one hour chase in wildtype but not NPC1-deficient cells, con-
sistent with the well documented defect in cholesterol egress in
NPC. It is, however, possible that a proportion of the probe was
trafficked from the plasma membrane to the ER in control cells
rather than across lysosome-ER contact sites. The most compel-
ling evidence for a role for MCS in direct cholesterol transport
from the endocytic pathway to the ER, however, is the ability to
reverse the cholesterol accumulation in NPC1-deficient cells by
artificially tethering late endocytic organelles to the ER. We used
a sterol-insensitive ORP1L mutant, that constitutively binds VAP
to act as an artificial tether but that cannot transport sterol, to
expand ER-lysosome MCS. Remarkably, MCS expansion by
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cholesterol accumulation in NPC1-deficient cells. ORP1L was
recently shown to mediate cholesterol egress from NPC1-
inhibited cells in a PI(4,5)P2/PI(3,4)P2-dependent manner8.
However, whereas cholesterol transport by ORP1L is dependent
on its ORD, here its tethering function alone was sufficient to
restore cholesterol egress. Thus even in the absence of NPC1,
cholesterol can be transported at lysosome-ER contacts, sug-
gesting that when the contacts are expanded, either another
protein, likely endogenous ORP1L or Gramd1b, can compensate
for loss of NPC1, or alternatively, cholesterol transport may occur
Fig. 5 Increased lysosome-mitochondria contact sites in NPC1-deficient cells. a Electron micrographs of HeLa cells treated with non-targeting control
siRNA (siCON), NPC1-siRNA (siNPC1) or with Gramd1b-siRNA (siGramd1b) showing lysosome MCSs (black arrows) with ER in control or mitochondria in
NPC1 or Gramd1b-depleted cells. Scale bar, 200 nm. b The percentage of endocytic organelles with a mitochondria MCS from a were quantified and
expressed as the mean of three independent experiments+ SEM. Welch two sample t-tests were performed between siCON and treatment conditions
(siNPC1:**P= 0.00615, siGramd1b:**P= 0.00412). c Electron micrograph of HeLa cells pulsed with HRP for 2 h prior to treatment with U18666A (2 µg/mL
for 18 h). Asterisks indicate HRP-containing organelles, identified by the electron-dense reaction product. Scale bar, 450 nm and 200 nm in boxed
enlargement d Representative electron micrographs of HeLa cells treated with U18666A (2 µg/mL for 18 h) and stained for endogenous Tom20 using pre-
embedding labelling. Tom20-stained OMM appears to surround the lysosome. Scale bar, 100 nm. e Slices from a tomographic reconstruction from HeLa




























































Fig. 6 STARD3-dependent association of mitochondria with cholesterol-rich lysosomes with reduced ER contact. a Electron micrograph of HeLa cells
treated with U18666A (2 µg/mL for 18 h) showing apparent engulfment of a lysosome by a mitochondria. Cholesterol was stained with PFO using pre-
embedding labelling. “Engulfed” lysosomes are rich in PFO-stained cholesterol. Scale bar, 200 nm and 100 nm in boxed enlargement. b Representative
electron micrographs showing lysosome contact sites (arrows) with ER or mitochondria in fibroblasts derived from healthy donors (control), fibroblasts
from NPC1-patients (NPC1) or NPC1 patient fibroblasts treated with siSTARD3 (NPC1/siSTARD3). Scale bar, 200 nm. c The percentage of lysosomes with
a mitochondria MCS from b are presented as mean from 3 independent experiments+ SEM. d, e STARD3-GFP was co-expressed with APEX2-GBP in
d control HeLa cells, or e HeLa cells treated with U18666A (2 µg/mL for 18 h) prior to preparation for EM. Electron dense APEX reaction product (STARD3-
GFP) localizes to extended ER contacts with late endocytic organelles in control cells (d), but to lysosome-mitochondria MCS on NPC1 inhibition (e).
Arrows, MCSs. Scale bar, 200 nm
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along a concentration gradient across the expanded contact
without the need for a sterol transporter. While the precise
mechanism of transport remains unclear, that MCS expansion
also corrected the reduced esterification phenotype in NPC1-
deficient cells indicates that ER-lysosome MCS can act as con-
duits for the transport of LDL-derived cholesterol to the ER for
esterification. Our data thus favours a model of multiple pathways
of transport of LDL-cholesterol to the ER4, likely operating at
different stages of endosome maturation as the LDL cholesterol
ester core is progressively hydrolysed. In such a model, a pro-
portion of the LDL cholesterol ester core is only hydrolysed in the
more acidic environment of the lysosome that is optimal for acid
lipase activity. The resulting remaining LDL-derived cholesterol is
cleared from the lysosome across ER-lysosome MCS. In the
absence of NPC1, two important pathways for cholesterol
transport to the ER are disrupted: Rab8-dependent cholesterol
recycling to the plasma membrane and direct transport across
ER-lysosome MCS. However, the cholesterol that accumulates in
the lysosome as a consequence of NPC1 loss can be directly
transported to the ER by artificial expansion of the ER-lysosome
interface.
It is interesting that cholesterol egress can be restored even in
the absence of NPC1, which has been shown to receive choles-
terol from luminal NPC236. NPC2 can transfer cholesterol
between phospholipid liposomes in the absence of NPC137 and is
thought to transfer cholesterol directly to the limiting membrane,
as well as to other transmembrane proteins38. NPC2 was also
shown to contribute to endosomal cholesterol transport to the
mitochondria in an NPC1-independent manner39. Thus, in cells
lacking NPC2, even though NPC1/Gramd1b-mediated contacts
are still formed, cholesterol is no longer delivered to the limiting
membrane of late endosomes/lysosomes and is therefore inac-
cessible for transport across the contact. The restoration of cho-
lesterol egress by MCS expansion when NPC1 is inhibited may
offer potential for the development of novel therapeutics for NPC
and other lysosomal storage diseases.
Imaging MCS by EM, we have uncovered an unexpected
expansion of an MCS population that forms between lysosomes
and mitochondria in cells depleted of NPC1 or Gramd1b.
Vacuole-mitochondria MCS were previously identified in
yeast40,41, where the extent of different MCS populations is
coordinated by enrichment of the sterol-binding protein Lam6 at
different MCS populations in response to the physiological con-
dition42. Similarly we found the localisation of the sterol-binding
protein, STARD3, at lysosome MCS with the ER versus mito-
chondria to be dependent on the sterol environment of the
endocytic pathway. In mammalian cells, lysosome-mitochondria
contacts have been described in developing erythroid cells43, and
in hypoxic cells, likely functioning in lysosome-mediated degra-
dation of damaged outer mitochondrial membrane protein44.
Four sub-populations of lysosome-mitochondria MCS were
recently described45 and reciprocal regulation of lysosomal Rab7
activity and mitochondrial dynamics has been demonstrated at
these MCS46. Previous studies have shown that cholesterol
accumulation in NPC cells inhibits Rab7 GTP hydrolysis,
resulting in elevated membrane-associated Rab747. Interestingly,
Rab7 hydrolysis at the lysosome-mitochondria interface is
required for MCS disassembly46. Thus, the resistance of Rab7
GTP to hydrolysis in cholesterol-laden lysosomes might con-
tribute to the extended mitochondrial MCS in NPC1 or
Gramd1b-deficient cells. This expansion of lysosome-
mitochondria MCS may offer an alternative route to clear cho-
lesterol from the endocytic pathway and a potential mechanism
for the elevated cholesterol in the mitochondria of NPC1-
deficient cells26. The observation that STARD3 depletion reduced
lysosome-mitochondria contacts to a level below that in control
cells indicates an essential role for STARD3 in the formation of
this MCS population. In the context of STARD3’s known role in
regulating cholesterol transport to the mitochondria26, our data
suggest a function for lysosome-mitochondria MCS in cholesterol
transport, possibly in an attempt to rescue cholesterol-induced
lysosomal stress. However, the resulting cholesterol accumulation
in the mitochondria is associated with mitochondrial dysfunction
in NPC48,49. Indeed increased mitochondrial cholesterol content
on STARD3 overexpression resulted in reduced ATP generation,
increased mitochondrial superoxide levels and other indicators of
mitochondrial dysfunction50. The absence of expanded ER-
endosome MCS in STARD3-overexpressing cells when treated
with U18666A, where endocytic organelles are laden with lipid,
suggests that like ORP1L, STARD3 interaction with VAP may
also be sterol sensitive. Thus, a picture of sterol responsive late
endosome/lysosome MCS populations is emerging (summarised
in Fig. 7) whereby in the presence of sterols, NPC1 interacts with
Gramd1b to provide platforms for LDL-derived cholesterol
transport to the ER that is dependent on luminal NPC2 to deliver
the cholesterol to the limiting membrane. When this fails and
cholesterol accumulates in endocytic organelles, STARD3 med-
iates expansion of lysosome-mitochondria contacts, though how
it anchors to the mitochondria is as yet undetermined. Critically,
expansion of the ER-lysosome interface corrects the cholesterol
accumulation in NPC1-deficient cells.
Taken together, our data demonstrate an essential role for MCS
in LDL-cholesterol egress and describe a role for NPC1 in
establishing contacts between late endosomes/lysosomes and the
ER, thereby challenging the notion that the sole function of NPC1
is that of a cholesterol transport protein. Our findings instead
indicate that, through the interaction with Gramd1b, NPC1 also
plays an important role in the formation of MCS, which serve as
conduits for cholesterol transport. In NPC1-deficient cells, where
cholesterol transport to the ER is impaired, STARD3 promotes
the association of cholesterol-laden lysosomes with mitochondria,
providing a likely mechanism for the mitochondrial cholesterol
accumulation and dysfunction in NPC. These data, together with
the sterol-dependent interaction between NPC1 and Gramd1b,
demonstrate how heavily influenced late endocytic organelle MCS
populations are by the sterol environment. Thus sterol egress
from the endocytic pathway at MCS is regulated, at least in part,
by the cholesterol to be transported, with NPC1-tethered MCS
playing a central and sterol-responsive role in regulating the
sterol environment of the endocytic pathway.
Methods
Cell culture and transfection. HeLa (ATCC: CCL2), CHO (WT: ATCC CRL-
9618, NPC: CHO-M12, PMID 10964915) and fibroblast (Coriell Institute:
GM05399 Control, GM03123/GM22870 NPC1 patient, GM18455 NPC2 patient)
cells were cultured in DMEM/10% FBS (Invitrogen). Cells were transfected using
Lipofectamine LTX Plus for plasmids and Lipofectamine RNAiMax (Invitrogen)
for siRNAs, according to manufacturer’s instructions. HeLa NPC1−/− cells in
which NPC1 was knocked out using CRISPR/Cas9 genome editing were kindly
provided by Dr. Wim Annaert (VIB Center for Brain & Disease Research, Leuven,
Belgium). (PMID: 28134274).
Antibodies. Mouse anti-VAPA (MAB5820) and VAPB (MAB58551) antibodies
were from R&D Systems (diluted 1:250 and 1:500 respectively), rabbit anti-LAMP1
was purchased from Cell Signalling (D2D11, diluted 1:100), rabbit anti-NPC1
(immunoEM, diluted 1:50) was a kind gift from Elina Ikonen (University of
Helisinki), rabbit anti-NPC1 (WB, diluted 1:2000) and rabbit anti-Gramd1b
(diluted 1:800 for WB, 1:10 for immunno-EM) were from Abcam (EPR5209 and
ab154934 respectively), and rabbit anti-STARD3 (diluted 1:1000) was a kind gift
from Catherine Tomasetto (IGBMC, France). Antibody to the extracellular domain
of EGFR used for gold conjugation was isolated from the Mab 108 hybridoma
(ATCC, HB-9764).
Plasmids. wtORP1L-GFP, ORP1L-deltaORD-GFP and ORP1L-FFATmut-GFP
were a kind gift from Jacques Neefjes (Netherlands Cancer Institute). STARD3-
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GFP was a kind gift from Fabien Alpy (IGBMC, France). Gramd1-GFP plasmids
were a kind gift from Alberto Gatta/Tim Levine (UCL). To generate NPC1-GFP,
NPC1 was cloned from pSG5-NPC1 (kind gift from Yiannis Ioannou, Mount Sinai
School of Medicine) into pEGFP-C1 at EcoR1/BamH1 sites. APEX2-GBP was a gift
from Rob Parton (Addgene plasmid #67651). Sec61-GFP plasmid was a gift from
Eric Schirmer (Addgene plasmid #26008).
siRNAs. The non-targeting control siRNA was Allstars negative control siRNA
(Qiagen 1027281). siRNA smart pools targeting VAPA (M-021382-01), VAPB (M-
017795-00) and Gramd1b (M-026529-01) were synthesized by Dharmacon. siRNA
targeting NPC115 (target sequence: 5′-ACCAATTGTGATAGCAATATT-3′), and
STARD3 (target sequence: 5′-AACACAGGCATCCGTAAGAAC-3′) were syn-
thesized by Qiagen.
Western blotting and immunoprecipitation. For Western blotting, cells were
lysed in lysis buffer [40 mM HEPES, 80 mM NaCl, 10 mM EDTA, 10 mM EGTA,
1% Triton-X100, protease inhibitor cocktail (Calbiochem set I), phosphatase
inhibitor cocktail (Calbiochem set II)]. Lysates were fractioned by SDS–PAGE on
10% gels under reducing conditions and immunoblotted on nitrocellulose mem-
branes. Following incubation with infrared-fluorophore-conjugated secondary
antibodies (1:8000), membranes were scanned in an Odyssey SA scanner (LI-COR
Biosciences). For IP, cells were lysed as above following crosslinking for 30 min at
RT in DSP crosslinking solution (1 mM DSP, 10 mM Triethanolamine, 0.25 M
sucrose, 2 mM CaCl2, pH 7.4) and blocking for 30 min at RT in blocking solution
(10 mM triethanolamine, 0.25 M sucrose, 2 mM CaCl2, 50 mM Ethanolamine, pH
7.4). NPC1 immunoprecipitates were fractioned, immunoblotted and scanned as
described for Western blotting. Supplementary Fig. 7 shows uncropped blots for
Fig. 2a, c.
Electron microscopy. For conventional EM, cells were serum starved for 1 h prior
to stimulation with 100 ng/ml EGF (Sigma) with 10 nm anti-EGFR gold conjugate
in DMEM/0.2% BSA. After fixation in 2% paraformaldehyde (PFA)/2% glutar-
aldehyde for 30 min, cells were post-fixed in 1% osmium tetroxide, 1.5% potassium
ferricyanide, incubated in 1% uranyl acetate, dehydrated and embedded in TAAB-
812 resin. For U18666A-mediated inhibition of NPC1, cells were incubated with
2 µg/mL U18666A (Calbiochem) for 18 h prior to fixation. Cells transfected with
APEX2-GBP were incubated with 1.5 mg/ml DAB (TAAB) in TRIS buffer sup-
plemented with 0.02% H2O2 for 30 min following fixation. For correlative light and
electron microscopy (CLEM), live cell imaging of cells expressing NPC1-GFP
cultured on gridded dishes (Mat-tek) was followed by fixation and embedding for
EM. For Filipin staining, cells were fixed in 4% PFA prior to incubation with
100 μγ/μλ Filipin (Sigma) in PBS for 45 min and imaged by fluorescent microscopy
prior to fixation and embedding for EM. Expressing cells were identified using grid
coordinates and imaged by EM. Electron micrographs were montaged in Adobe
Photoshop and fluorescent images overlaid.
Immuno-EM. For pre-embedding labelling, cells were fixed in 4% PFA, permea-
bilised in either 40 μg/ml digitonin (Calbiochem) in PBS for 15 min for NPC1 or
Gramd1b labelling, or 0.05% triton in PHEM (60 mM Pipes, 25 mM Hepes, 10 mM
EGTA, 2 mM MgCl2, PH 7) for 5 min on ice for PFO labelling and incubated with
anti-NPC1 (1:25) or PFO-gst (20 μg/ml) followed by rabbit anti-GST (1:40) and
nanogold-secondary antibodies (Nanoprobes, 1:200) prior to fixation for EM in 2%
PFA/2% glutaraldehyde, followed by gold enhancement (Nanoprobes), according
to manufacturer’s instructions. Post-fixation and embedding were as for conven-
tional EM. For cryo-immunoEM, cells were fixed in 4% PFA/0.1% Gluteraldehyde
in 0.1 M phosphate buffer for 2 h at RT, scraped in 1% gelatin and pellets resus-
pended in 12% gelatin. Pelleted cells were cooled on ice and 1 mm square blocks
were cut and infused with 2.3 M sucrose rotating at 4 °C overnight. Blocks were
mounted onto pins in liquid nitrogen and 80 nm sections cut at −120 °C. Ultrathin
cryo-sections were collected in 2% methyl cellulose/2.3 M sucrose onto formvar-
coated copper grids prior to labelling with 20 μg/ml PFO-GST25 followed by rabbit
anti-GST (1:40) and proteinA-gold (1:50). Sections were stained with 1.8% methyl
cellulose/0.4% uranyl acetate and imaged by EM.
EM quantitation. EGFR-MVBs were distinguished from nonEGFR-MVBs by the
presence of gold particles and lysosomes were identified by the presence of multi-
lamellar whorls. MCS between the ER and MVBs were classified as areas where the
opposing membrane were within 30 nm of each other with no minimum length.
For quantitation of %endocytic organelle membrane in contact with the ER, the
sum of MCS lengths (measured in ImageJ)/organelle was divided by the total
length of the organelle limiting membrane. A minimum of 60 organelles was
included for each condition. For MCS quantitation, means, standard errors of
means (SEM) and paired, two-tailed students T-tests were calculated in excel, with
p values > 0.05 represented as not significant (ns), * < 0.05, ** < 0.01 and *** < 0.001.
Fluorescence imaging. For live-cell imaging, cells were cultured in an 8-well glass
bottom slide (Ibidi, #80827) and transfected with Sec61-GFP DNA (75 ng per well).
Immediately prior to imaging, cells were labelled with 100 nM Lysotracker Red
DND-99 (Thermo Fisher, #L7528) for 10 min and washed with imaging buffer
(20 mM HEPES, 115 mM NaCl, 1.2 mM MgCl2, 1.2 mM K2HPO4, 1.8 mM CaCl2
and 0.2 % (w/v) glucose). Cells were kept in imaging buffer for the duration of
image acquisition on a Leica TCS SP8 microscocpe.
For imaging of fixed cells, cells were cultured onto 11 mm coverslips placed in
wells of a 24-well plate and transfected with the plasmids of interest (ORP1L-GFP,
ORP1L-ΔORD-GFP, ORP1L-FFATmut-GFP). The medium was replaced with
DMEM for 1 h and cells were fixed with 4% PFA for 1 h at room temperature. After
quenching of the paraformaldehyde with glycine (1.5 mg/ml PBS) for 10 min, cells
were stained with Filipin (0.05 mg/ml in PBS/10%FBS) for 2 h at room
temperature. The coverslips were washed, mounted onto glass slides using Prolong
Gold antifade reagent (Invitrogen) and imaged on a Leica TCS SP8 microscope and
LAS X software. For CLEM, cells were imaged with a Nikon Eclipse Ti-E. For LDL







Fig. 7 Reciprocal relationship between lysosomal cholesterol and NPC1-regulated MCS. A schematic representation of cholesterol transport at NPC1-
regulated lysosomal MCSs. In the presence of cholesterol in the endocytic pathway, lysosomal NPC1 interacts with Gramd1b on the ER to tether MCSs that
mediate the transport of cholesterol from the endosome to the ER for esterification by ACAT. In the absence of functional NPC2, luminal cholesterol fails to
be delivered to the limiting membrane for egress at NPC1-Gramd1b tethered MCS and therefore accumulates in the lysosome. In the absence of functional
NPC1, NPC1-tethered lysosome-ER contact sites are lost and cholesterol accumulates in the lysosome. Under these conditions STARD3 mediates extended
lysosome contact sites with mitochondria. However, when the lysosome is artificially tethered to the ER by expression of an ORP1L mutant with its sterol-
binding domain deleted (ORP1L-ΔORD), cholesterol transport to the ER is restored
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washed and chased in full medium for 10 min prior to fixation with 4% PFA in PBS
for 20 min. Images were acquired with a Leica TCS SP8 microscope and LAS X
software.
Visualization of clickable and photocrosslinkable cholesterol (pacChol) in
cells. Cells were seeded onto 11 mm coverslips placed in wells of a 24-well plate to
65–75% confluency PacChol/BSA complexes were prepared according to the
protocol of Martínez et al.51. Brielfy, 0.6 mg pacChol was dissolved in 60 µl EtOH
(1 % (w/v)) and diluted with 60 µl H2O. The pacChol, EtOH and H2O mixture was
vortexed and centrifuged (2000 rpm, 10 min, 4 °C). The supernatant was discarded,
and the pellet was resuspended in 60 µl 0.25 M sucrose/1 mM EDTA, pH 7.3.
24 mg fatty acid-free BSA were added and dissolved while shaking at RT. Once the
BSA was completely dissolved, the pacChol/BSA mixture was centrifuged (12000
rpm, 10 min, 4 °C). The supernatant containing pacChol/BSA was collected and
used for cell labelling. Cells were starved for 2 h in serum-free DMEM, labelled
with 20 µM pacChol/BSA complex for 20 min and chased for indicated times in
serum-free DMEM. Subsequently, cells were washed with 1 mL PBS/0.01 mM CD
for 5 min at 37 °C followed by two washes with PBS at RT. Cells were overlaid with
0.5 ml of cold imaging buffer (20 mM HEPES, 115 mM NaCL, 1.2 mM MgCl2,
1.2 mM glucose and 1.8 mM CaCl2, pH 7.4/NaOH), and UV-irradiated (λ~365
nm) on ice for 5 min. Cells were immediately fixed with pre-cooled MeOH at −20 °
C for 20 min. Non–cross-linked lipids were extracted by washing three times with
0.78 mL of CHCl3/MeOH/AcOH (10:55:0.75) (v/v) and twice with PBS. Cells were
then incubated with 50 μl of click mixture (1 µl 2 mM Alexa-488-azide or Alexa-
555-azide, 125 µl 10 mM Cu(I)BF4 in acetonitril and 0.5 ml PBS) for 1 h at room
temperature in the dark. Cells were then washed with PBS and incubated with 50
μL of primary α-LAMP1 antibody (1:200 in PBS supplemented with 2% BSA and
0.3% Triton X-100) for 1 h in the dark. Coverslips were briefly washed with PBS
and incubated with secondary antibody (α-rabbit conjugated to AlexaFluor488,
1:800) for 30 min–1 h, washed briefly with PBS, and mounted in ProLong Gold
Antifade mounting medium. Microscopy images were captured using a confocal
laser scanning microscope (Zeiss LSM800) with a 63× oil objective.
Image analysis. Images were analysed on Fiji (W. Rasband, NIH, USA) using the
FluoQ macro52 for automatic extraction of intensity and co-localization values.
These values were subsequently loaded in R and grouped according to conditions.
Graphs were generated using the ggplot2 package in R53.
Measurement of cholesterol and cholesterol esters. For the Amplex Red
Cholesterol Assay (Thermo Fisher Scientific, CA, USA), aliquots of cell pellet
sonicates were incubated for 30 min at 37 °C in the presence of 2 U/mL of HRP, 2
U/mL cholesterol oxidase, and 300 µM Amplex Red reagent. The assay was per-
formed with and without addition of 0.2 U/mL cholesterol esterase, and esters
determined by calculating the total minus free cholesterol. Fluorescence was
measured with an Infinite M1000 pro plate reader (Tecan Group Ltd., Switzerland).
Statistical analyses. All biochemical data were from biological triplicates unless
otherwise indicated, whereas imaging data was quantified from multiple cells as
indicated in the figure legends. Statistical analysis was performed with a Welch two
sample t-test for comparison of two groups using R. Significance is indicated using
asterisks (***P ≤ 0.001, **P ≤ 0.01, *P ≤ 0.05)
Data availability
Data supporting the findings in this study are available from the corresponding author
upon reasonable request.
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